Bodhi Tree Biotechnology (BDTB) EBIT Margin (2024 - 2025)
Bodhi Tree Biotechnology (BDTB) reported EBIT Margin of 89.06% for Q3 2025, up 93.13% quarter-over-quarter from 1295.54% in Q4 2024.
Bodhi Tree Biotechnology (BDTB) EBIT Margin (2024 - 2025) Analysis & Trends
Bodhi Tree Biotechnology (BDTB) has 2 years of EBIT Margin data on file, last reported at 89.06% in Q3 2025.
- EBIT Margin for Q3 2025 came in at 89.06%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 1131.58% (changed N/A YoY), and the FY2025 annual result was 868.34%, down 69133.0% from the prior year.
- EBIT Margin rose to 89.06% in Q3 2025 per BDTB's latest filing, from 1295.54% in the prior quarter.
- Over five years, EBIT Margin peaked at 89.06% in Q3 2025 and troughed at 1295.54% in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -89.06% |
| Dec 31, 2024 | -1,295.54% |